Establishment Labs Files 8-K
Ticker: ESTA · Form: 8-K · Filed: Jun 5, 2024 · CIK: 1688757
| Field | Detail |
|---|---|
| Company | Establishment Labs Holdings Inc. (ESTA) |
| Form Type | 8-K |
| Filed Date | Jun 5, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k
Related Tickers: ESTA
TL;DR
ESTA filed an 8-K, likely a routine update, no major news yet.
AI Summary
Establishment Labs Holdings Inc. filed an 8-K on June 5, 2024, to report other events. The filing does not contain specific details about the nature of these events, dollar amounts, or new agreements, but it serves as a notification to the SEC and investors.
Why It Matters
This filing indicates that Establishment Labs Holdings Inc. has reported an event requiring disclosure to the SEC, which could be material to investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for 'Other Events' and lacks specific details that would indicate immediate high risk.
Key Players & Entities
- ESTABLISHMENT LABS HOLDINGS INC. (company) — Registrant
- 0001688757-24-000065 (filing_id) — Accession Number
- June 5, 2024 (date) — Date of Report
- British Virgin Islands (jurisdiction) — State of Incorporation
- NASDAQ (exchange) — Stock Exchange
FAQ
What specific event is Establishment Labs Holdings Inc. reporting in this 8-K filing?
The filing is categorized under 'Other Events' and does not specify the exact nature of the event in the provided text.
When was this 8-K filing submitted to the SEC?
The filing was submitted on June 5, 2024.
What is the principal executive office address for Establishment Labs Holdings Inc.?
The principal executive offices are located at Building B15 and 25 Coyol Free Zone, Alajuela, Costa Rica.
What is the Commission File Number for Establishment Labs Holdings Inc.?
The Commission File Number is 001-38593.
What is the Standard Industrial Classification (SIC) code for Establishment Labs Holdings Inc.?
The SIC code is 3842, for Orthopedic, Prosthetic & Surgical Appliances & Supplies.
Filing Stats: 452 words · 2 min read · ~2 pages · Grade level 12.2 · Accepted 2024-06-05 07:02:08
Filing Documents
- esta-20240605.htm (8-K) — 26KB
- 0001688757-24-000065.txt ( ) — 150KB
- esta-20240605.xsd (EX-101.SCH) — 2KB
- esta-20240605_lab.xml (EX-101.LAB) — 22KB
- esta-20240605_pre.xml (EX-101.PRE) — 13KB
- esta-20240605_htm.xml (XML) — 3KB
01 Other Events
Item 8.01 Other Events. On June 5, 2024, during the 2024 Jefferies Global Healthcare Conference, Establishment Labs (the "Company") is announcing that the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) has completed its review of the Company's premarket approval application (PMA) for Motiva Implants and has issued a letter to the Company instructing that the PMA is approvable subject to an acceptable FDA inspection of the Company's manufacturing facilities. The inspection by the FDA has been rescheduled from the previously confirmed dates to take place within the next thirty days.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. ESTABLISHMENT LABS HOLDINGS INC. Dated: June 5, 2024 By: /s/ Rajbir S. Denhoy Name: Rajbir S. Denhoy Title: Chief Financial Officer